Evidence map›Paper›PMID 17031559›Full record

ArticleJournal of neuro-oncology2007

PLXDC1 (TEM7) is identified in a genome-wide expression screen of glioblastoma endothelium.

Robert M Beaty, Jennifer B Edwards, Kathy Boon, I-Mei Siu, James E Conway, Gregory J Riggins

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Selective blockade of tumor angiogenesis.Cell cycle (Georgetown, Tex.) · 2012
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Clinical biomarkers of angiogenesis inhibition.Cancer metastasis reviews · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Robert M BeatyDepartment of Neurosurgery, Johns Hopkins University Medical School, CRB II Rm. 257 , 1550 Orleans Street, Baltimore, MD, 21231, USA.
Jennifer B Edwards
Kathy Boon
I-Mei Siu
James E Conway
Gregory J Riggins
Johns Hopkins University · US

Funding

Glioblastoma Genome Project to Locate Molecular TargetsR01NS052507 · NINDS · JOHNS HOPKINS UNIVERSITY · PI RIGGINS, GREGORY JOSEPH · 2006 to 2009
$2.3M
NINDS NIH HHS R01 NS052507
6 · The paper itself

Abstract

Glioblastomas are a highly aggressive brain tumor, with one of the highest rates of new blood vessel formation. In this study we used a combined experimental and bioinformatics strategy to determine which genes were highly expressed and specific for glioblastoma endothelial cells (GBM-ECs), compared to gene expression in normal tissue and endothelium. Starting from fresh glioblastomas, several rounds of negative and positive selection were used to isolate GBM-ECs and extract total RNA. Using Serial Analysis of Gene Expression (SAGE), 116,259 transcript tags (35,833 unique tags) were sequenced. From this expression analysis, we found 87 tags that were not expressed in normal brain. Further subtraction of normal endothelium, bone marrow, white blood cell and other normal tissue transcripts resulted in just three gene transcripts, ANAPC10, PLXDC1(TEM7), and CYP27B1, that are highly specific to GBM-ECs. Immunohistochemistry with an antibody for PLXDC1 showed protein expression in GBM microvasculature, but not in the normal brain endothelium tested. Our results suggest that this study succeeded in identifying GBM-EC specific genes. The entire gene expression profile for the GBM-ECs and other tissues used in this study are available at SAGE Genie (http://cgap.nci.nih.gov/SAGE). Functionally, the protein products of the three tags most specific to GBM-ECs have been implicated in processes critical to endothelial cell proliferation and differentiation, and are potential targets for anti-angiogenesis based therapy.

Indexed as

Brain NeoplasmsComputational BiologyEndothelial CellsEndothelium, VascularExpressed Sequence TagsGene ExpressionGene Expression ProfilingGene LibraryGlioblastomaHumansImmunohistochemistryNeoplasm ProteinsReceptors, Cell SurfaceSequence Tagged SitesNeoplasm ProteinsPLXDC1 protein, humanReceptors, Cell Surface

Identifiers

PMID17031559
OpenAlexW2058173737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.